Drug Cos. Urge Full Fed. Circ. To Hear Teva Orange Book Row
By Andrew Karpan · February 6, 2025, 7:47 PM EST
The branded pharmaceutical industry is lining up behind a legal effort from Israeli drugmaker Teva that wants the full Federal Circuit to hear a dispute over delisting patents from the U.S....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login